Filter
883
Text search:
Pharmaceuticals
Featured
Recommendations
69
New Publications
264
Language
Document type
No document type
485
Guidelines
141
Studies & Reports
132
Manuals
52
Strategic & Response Plan
31
Training Material
11
Resource Platforms
11
Fact sheets
9
Situation Updates
6
Brochures
2
Online Courses
2
Infographics
1
Countries / Regions
Ethiopia
44
India
36
Kenya
31
Global
20
Uganda
19
Liberia
18
Nepal
17
Tanzania
16
Nigeria
15
Rwanda
15
Ghana
14
Bangladesh
14
Western and Central Europe
14
Philippines
13
South Africa
13
Namibia
13
Lesotho
11
Sierra Leone
10
Myanmar / Burma
10
Germany
9
Zambia
9
Malawi
9
Ukraine
9
Zimbabwe
8
Cambodia
8
Eswatini/ Swaziland
8
Congo, Democratic Republic of
6
Syria
6
Indonesia
6
Eastern Europe and Central Asia
6
Guinea
5
Botswana
5
Latin America and the Carribbean
5
Africa
5
Senegal
4
South Sudan
4
Benin
4
South–East Asia Region
4
Eastern Europe
4
Haiti
3
Thailand
3
Madagascar
3
Cameroon
2
Pakistan
2
Lebanon
2
Mozambique
2
Angola
2
Yemen
2
East and Southern Africa
2
Paraguay
2
Albania
2
Burkina Faso
1
Mali
1
USA
1
Iraq
1
Jordan
1
China
1
Ireland
1
Papua New Guinea
1
Sudan
1
Peru
1
Brazil
1
North Macedonia
1
Libya
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Bhutan
1
Palestine
1
Tajikistan
1
Russia
1
Moldova
1
Iran
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
369
Clinical Guidelines
55
Public Health
43
Key Resources
33
Women & Child Health
23
Pharmacy & Technologies
23
Capacity Building
6
Protection & Security
1
Toolboxes
Pharmacy
141
AMR
62
COVID-19
43
Mental Health
39
TB
36
HIV
29
Rapid Response
27
Planetary Health
27
Ebola
18
Global Health Education
17
Caregiver
16
Conflict
13
NTDs
13
NCDs
12
Health Financing Toolbox
10
Refugee
8
Specific Hazards
8
Polio
6
Natural Hazards
6
Disability
3
Cholera
2
Social Ethics
2
South Sudan
1
The following checklist can help hospitals assess and improve their preparedness for responding to a community-wide outbreak of COVID-19. Each hospital will need to adapt this checklist to meet its unique needs and circumstances. This checklist should be used as one of several tools for evaluating c
...
It is too early to know the full impact of COVID-19 on Africa. To date the experience has been varied. There are causes for concern, but also reasons for hope. Early estimates were pessimistic regarding the pandemic’s impact on the continent. But the relatively low numbers of COVID-19 cases report
...
Improvements in water sanitation and hygiene (WASH) and wastewater management in all sectors are critical elements of preventing infections and reducing the spread of antimicrobial resistance (AMR) as identified in the Global Action Plan to combat AMR. Yet, at present, WASH and wastewater management
...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
BMJ Global Health2020;5:e002914. doi:10.1136/bmjgh-2020-002914
The evidence produced in mathematical models plays a key role in shaping policy decisions in pandemics. A key question is therefore how well pandemic models relate to their implementation contexts. Drawing on the cases of Ebola and in
...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
2020 was a year like no other. Amidst on-going humanitarian crises, largely fuelled by conflict and violence but also driven by the effects of climate change – such as the largest locust infestation in a generation – the world had to contend with a global pandemic. In less than one year (March-D
...
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
Web annex 2: Carbetocin versus placebo or no treatment
Evidence to decision framework
The pandemic presents tough choices for governments, local communities, health and school systems, as well as families and businesses: How to re-open safely? How to safeguard people’s lives and protect their livelihoods? Where to allocate scarce resources? How to protect those unable to protect th
...
In India, in response to the above and guided by our counterparts in the government of India, the UN agencies have developed the Novel Coronavirus Disease Joint Health Response Plan by UN Agencies and Partners, led by WHO-India, in close collaboration with the Ministry of Health and Family Welfare,
...
The COVID-19 pandemic has provided a dramatic illustration of the extent to which the health of people, animals and the environment is interdependent, which is why “One Health” is now high on the political agenda. This document provides an overview of KfW Development Bank’s approach to promoti
...
WHO Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities
recommended
The aim of this guidance is to enhance the capacity of health care facilities to protect and improve the health of their target communities in an unstable and changing climate; and to empower health care facilities to be environmentally sustainable, by optimizing the use of resources and minimizing
...
WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050.
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal and plant sectors, and their release into the environment. The purpose of the document is to identify existing instruments and standards in
...
Measuring progress towards universal health coverage.
This sixth edition of Health at a Glance Asia/Pacific presents a set of key indicators of health status, the determinants of health, health care resources and utilisation, health care expenditure and financing and quality of care across 27 Asia-
...
